由新冠病毒辉瑞-生物科技mRNA疫苗诱发的复发性巨细胞性蜂窝织炎样斯威特综合征
Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.
作者信息
Hirt Penelope, Park Lily, Wallace Carly E, Kerdel Francisco
机构信息
Department of Dermatology, Larkin Community Hospital, Miami, FL.
Lake Erie College of Osteopathic Medicine, Bradenton, FL.
出版信息
Dermatol Reports. 2023 May 23;15(3):9668. doi: 10.4081/dr.2023.9668. eCollection 2023 Sep 12.
Primary and booster vaccines for SARS-CoV-2 are the most effective methods of preventing infection and are generally considered safe. However, many cutaneous adverse events have been reported following vaccination. To date, there have been seven reported cases of Sweet syndrome occurring after the first dose of the SARS-CoV-2 vaccine. We describe a rare case of atypical giant-cellulitis like Sweet syndrome reemerging after receiving the SARS-CoV-2 booster vaccine.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的初级疫苗和加强疫苗是预防感染的最有效方法，并且通常被认为是安全的。然而，接种疫苗后已报告了许多皮肤不良事件。迄今为止，已有7例在接种第一剂SARS-CoV-2疫苗后发生Sweet综合征的报告病例。我们描述了1例罕见的非典型巨细胞性蜂窝织炎样Sweet综合征在接种SARS-CoV-2加强疫苗后复发的病例。
Zotero 插件